UroToday.com· @urotoday · X·· 21 小时前评分45
正文 · 原文
SWOG S2200: Cabozantinib with or Without Atezolizumab in Metastatic Papillary RCC. Presented by @maughanonc @huntsmancancer. #ESMO26 written coverage by @rksayyid @UAUrology > https://bit.ly/4yLiKH1 #KidneyCancer #RCC #Immunotherapy @myESMO @SWOG
72 浏览 · 0 赞 · 0 转发 · 0 回复
来源：UroToday.com · x.com